| Product Code: ETC8921074 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, North Macedonia`s import of antibodies saw continued reliance on key exporting countries such as Germany, Switzerland, Denmark, Austria, and Sweden. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market landscape. Despite a healthy compound annual growth rate (CAGR) of 5.6% from 2020 to 2024, a slight decline in growth rate (-8.98%) from 2023 to 2024 suggests potential challenges or shifts in the market dynamics. Monitoring these trends and understanding the factors driving them will be crucial for stakeholders in the antibodies import sector in North Macedonia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Republic of Macedonia Antibodies Market Overview |
3.1 Republic of Macedonia Country Macro Economic Indicators |
3.2 Republic of Macedonia Antibodies Market Revenues & Volume, 2021 & 2031F |
3.3 Republic of Macedonia Antibodies Market - Industry Life Cycle |
3.4 Republic of Macedonia Antibodies Market - Porter's Five Forces |
3.5 Republic of Macedonia Antibodies Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Republic of Macedonia Antibodies Market Revenues & Volume Share, By Antibodes Type, 2021 & 2031F |
3.7 Republic of Macedonia Antibodies Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Republic of Macedonia Antibodies Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Republic of Macedonia Antibodies Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Republic of Macedonia Antibodies Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 Republic of Macedonia Antibodies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Republic of Macedonia Antibodies Market Trends |
6 Republic of Macedonia Antibodies Market, By Types |
6.1 Republic of Macedonia Antibodies Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Republic of Macedonia Antibodies Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Republic of Macedonia Antibodies Market Revenues & Volume, By Primary, 2021- 2031F |
6.1.4 Republic of Macedonia Antibodies Market Revenues & Volume, By Secondary, 2021- 2031F |
6.2 Republic of Macedonia Antibodies Market, By Antibodes Type |
6.2.1 Overview and Analysis |
6.2.2 Republic of Macedonia Antibodies Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.2.3 Republic of Macedonia Antibodies Market Revenues & Volume, By Polyclonal Antibodies, 2021- 2031F |
6.3 Republic of Macedonia Antibodies Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Republic of Macedonia Antibodies Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.3.3 Republic of Macedonia Antibodies Market Revenues & Volume, By Immunofluorescence, 2021- 2031F |
6.3.4 Republic of Macedonia Antibodies Market Revenues & Volume, By Western Blotting, 2021- 2031F |
6.3.5 Republic of Macedonia Antibodies Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.6 Republic of Macedonia Antibodies Market Revenues & Volume, By Immunoprecipitation, 2021- 2031F |
6.3.7 Republic of Macedonia Antibodies Market Revenues & Volume, By ELISA, 2021- 2031F |
6.4 Republic of Macedonia Antibodies Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Republic of Macedonia Antibodies Market Revenues & Volume, By Mouse, 2021- 2031F |
6.4.3 Republic of Macedonia Antibodies Market Revenues & Volume, By Rabbit, 2021- 2031F |
6.4.4 Republic of Macedonia Antibodies Market Revenues & Volume, By Goat, 2021- 2031F |
6.4.5 Republic of Macedonia Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Republic of Macedonia Antibodies Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 Republic of Macedonia Antibodies Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.5.3 Republic of Macedonia Antibodies Market Revenues & Volume, By Immunology, 2021- 2031F |
6.5.4 Republic of Macedonia Antibodies Market Revenues & Volume, By Oncology, 2021- 2031F |
6.5.5 Republic of Macedonia Antibodies Market Revenues & Volume, By Stem Cells, 2021- 2031F |
6.5.6 Republic of Macedonia Antibodies Market Revenues & Volume, By Neurobiology, 2021- 2031F |
6.5.7 Republic of Macedonia Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Republic of Macedonia Antibodies Market, By End use |
6.6.1 Overview and Analysis |
6.6.2 Republic of Macedonia Antibodies Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.6.3 Republic of Macedonia Antibodies Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.6.4 Republic of Macedonia Antibodies Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
7 Republic of Macedonia Antibodies Market Import-Export Trade Statistics |
7.1 Republic of Macedonia Antibodies Market Export to Major Countries |
7.2 Republic of Macedonia Antibodies Market Imports from Major Countries |
8 Republic of Macedonia Antibodies Market Key Performance Indicators |
9 Republic of Macedonia Antibodies Market - Opportunity Assessment |
9.1 Republic of Macedonia Antibodies Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Republic of Macedonia Antibodies Market Opportunity Assessment, By Antibodes Type, 2021 & 2031F |
9.3 Republic of Macedonia Antibodies Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Republic of Macedonia Antibodies Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Republic of Macedonia Antibodies Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 Republic of Macedonia Antibodies Market Opportunity Assessment, By End use, 2021 & 2031F |
10 Republic of Macedonia Antibodies Market - Competitive Landscape |
10.1 Republic of Macedonia Antibodies Market Revenue Share, By Companies, 2024 |
10.2 Republic of Macedonia Antibodies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |